Developer docs
API playgroundTry for free, no card

Search company profiles

VLife Sciences Technologies Pvt. Ltd.

Full company profile

uuid0033mlf

Namestring
VLife Sciences Technologies Pvt. Ltd.
Legal namestring
VLife Sciences Technologies Pvt. Ltd.
Company typeenum
Private
Founded yearint
2003
Descriptiontext

VLife Sciences Technologies Pvt. Ltd. is a Pune, India-based provider of computational molecular discovery and drug design software, operating as a division of NovaLead Pharma Pvt. Ltd. since October 2013. Founded in 2003, the company builds and licenses an integrated software portfolio consisting of four core suites — VLifeMDS (flagship molecular design suite), QSARpro (quantitative structure-activity relationship analysis), BioPredicta (bioinformatics predictive analysis), and ChemXplor (cheminformatics exploration) — complemented by nine functional products covering protein modeling, molecular docking, QSAR modeling, lead optimization, and visualization. The underlying technology stack combines proprietary methods including GQSAR (Group-based QSAR), VLifeSCOPE (residue-ligand interaction modeling), kNN-MFA, and VLifeAutoQSAR for predictive modeling, virtual screening, lead optimization, scaffold hopping, and ADME/Tox prediction, supported by 300+ man-years of accumulated research experience and granted IP including a PCT patent on G-QSAR and an NCE patent on a multi-targeted pancreatic cancer compound discovered using VLife's computational platform.

The company's business model combines software licensing (Individual User and Organizational User subscriptions, quoted on request) with professional research services including NCE discovery and optimization, new indication discovery (IndiSwitch), shelf compound re-evaluation (ReViva), and 360° Go/No-Go decision support (Prometheus/ChemDiagnostic). VLife serves pharmaceutical companies, academic and research institutions, biotech firms, and chemicals/materials industry customers — with named enterprise customers including Sun Pharma, Cipla, Mylan Labs, Unichem, Watson Pharma, Reliance Industries, HUL, and government accounts such as CDC Atlanta, alongside academic users including IISc, IIT Madras, NIPER, and National University of Singapore. Distribution is via direct enterprise licensing, academic institution agreements, and authorized reseller networks in Africa (Inqaba Biotechnical, SNBCHEMTECH) and Korea (Insilicogen).

Demand generation relies on industry conferences (ACS, BioExpo, CPhi India, EuroQSAR), academic training workshops at partner institutions, peer-reviewed publications, an annual Best Research Publication Award, and direct engagement with research institutions. The company holds DSIR R&D facility recognition (2008) and the BIRAC Innovator Award (2015). Operating status remains active with a headcount in the 11-50 range, though most recent customer-agreement news dates to 2015-2018, suggesting limited visible momentum or expansion since.

Short descriptiontext

VLife Sciences Technologies, a Pune-based division of NovaLead Pharma, licenses computational drug discovery software (VLifeMDS, QSARpro, BioPredicta, ChemXplor) and provides research services to pharmaceutical companies, academic institutions, and chemicals/materials firms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPune, India
HQ citystring
Pune
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computational drug discovery, molecular modeling software, QSAR analysis tools, virtual screening software, computer-aided drug design
Industry3 codes
PRIMARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAFAM
In Silico / Computational Toxicology & PK/PD Modeling
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Software Publishers51321
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Computational Drug Discovery Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Licensing
TypeSubscription Recurring
Description

VLifeMDS, QSARpro, BioPredicta, ChemXplor - comprehensive software suites for computer-aided drug design and QSAR analysis. Licensed to academic institutions, pharmaceutical companies, and research organizations on subscription or perpetual license basis.

vlifesciences.com
2Research Services
TypeProfessional Services
Description

NCE discovery & optimization, New Indication discovery, Exploring shelf (Reviva), Go-no go decision support (ChemDiagnostic) - strategic research solutions for pharmaceutical pipeline enhancement.

vlifesciences.com
3Technology Services
TypeProfessional Services
Description

Custom technology development, research automation, algorithm development, and database management services for specific client needs.

vlifesciences.com
4Training Services
TypeProfessional Services
Description

Training programs, workshops, and hands-on sessions on computational drug design methods for academic and industry clients.

vlifesciences.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details2 tiers
1Individual User License
ModelSubscriptionBilling cadenceAnnual
Notes

Student, teacher, research scientist associated with academia, research institute and industry. No authorization needed while registering.

vlifesciences.com
2Organizational User License
ModelSubscriptionBilling cadenceAnnual
Notes

User registration on behalf of an organization. Authorization of parent institute or organization is mandatory.

vlifesciences.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

VLife Sciences Technologies develops and licenses computational molecular discovery and drug design software suites (VLifeMDS, QSARpro, BioPredicta, ChemXplor) that combine molecular modeling, QSAR analysis, virtual screening, protein modeling, and ADME/Tox prediction capabilities. In addition to software licensing, the company delivers strategic research services including NCE discovery and optimization, new indication discovery (IndiSwitch), shelved compound re-evaluation (ReViva), and Go/No-Go decision support (Prometheus), along with custom technology development and training programs for pharmaceutical, biotech, academic, and chemical/materials organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • First multi-targeted NCE in India for Pancreatic cancer discovered exclusively with computational technologies - now in advanced animal trials
+4 more records
Product overview1 text field

VLife Sciences Technologies is a provider of licensed computational drug discovery software and research solutions. The product portfolio consists of four integrated product suites (VLifeMDS, QSARpro, BioPredicta, and ChemXplor) complemented by nine functional products (VLifeBase, VLife Engine, ProModel, VLifeDock, VLifeQSAR, MolSign, LeadGrow, ChemDBS, and ProViz). VLifeMDS serves as the flagship comprehensive molecular modeling suite, while QSARpro focuses on advanced QSAR analysis. The functional products provide specialized capabilities including protein modeling, molecular docking, database management, lead optimization, and visualization, which integrate within the main suites to deliver complete computer-aided drug design workflows.

Product and service5 records
1VLifeMDS
CategoryCore software suite
Description

Comprehensive molecular design and drug discovery software suite providing tools for computer-aided molecular design, QSAR, molecular modeling, virtual screening, and ADME/Tox predictions; licensed to pharmaceutical companies, biotech firms, and academic institutions worldwide.

2QSARpro
CategoryCore software suite
Description

Advanced quantitative structure-activity relationship analysis suite for new molecule design and lead optimization; targeted at medicinal chemists performing SAR studies.

3BioPredicta
CategoryCore software suite
Description

Bioinformatics product for predictive analysis in drug discovery applications, focused on biological property prediction.

4ChemXplor
CategoryCore software suite
Description

Cheminformatics product for chemical data analysis, exploration, and visualization supporting drug discovery workflows.

5Computational Research Services
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
1Sun Pharma
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-10-01
Description

Sun Pharma entered into agreement with VLife for computational drug discovery services. Relationship has been renewed multiple times (2017).

vlifesciences.com
2Mylan Labs Ltd.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Mylan Labs Hyderabad entered into agreement with VLife for research services.

vlifesciences.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-10-01
Description

VLife Sciences became a division of NovaLead Pharma Private Limited in October 2013, with VLife providing technology platform and NovaLead conducting drug discovery research.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2013-08-01
Description

Unichem Laboratories entered into service agreement with VLife for drug discovery collaboration.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-07-01
Description

Cipla entered into service agreement with VLife for drug discovery collaboration. Multiple agreement renewals documented (2014, 2015, 2018).

6Watson Pharma
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-02-01
Description

Watson Pharma entered into agreement with VLife. Agreement renewed in 2014.

vlifesciences.com
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2010-04-01
Description

Strategic partnership to deliver high-speed virtual screening solutions combining VLife's computational drug design technology with CRL's high-performance computing capabilities.

8National Centre for Biological Sciences (NCBS), Bengaluru
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2010-03-01
Description

VLife contracted to develop specialized modeling and simulation technology for protein-protein interactions. Project undertaken jointly by NCBS, Stanford University (USA), and Technical University of Denmark for cutting-edge computational molecular discovery research.

vlifesciences.com
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2009-08-01
Description

Appointed as authorized reseller for Africa, expanding VLife's geographic reach in the African market.

10Insilicogen, Inc.
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2009-03-01
Description

Appointed as authorized reseller for Republic of Korea, enabling market presence in Korea.

vlifesciences.com
11SNBCHEMTECH
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2008-09-01
Description

Appointed as authorized reseller for Africa, expanding distribution network in African regions.

vlifesciences.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2008-05-01
Description

Research contract renewed for characterization and development of novel catalysts for olefin polymerization, focusing on ethylene oligomerization using Chromium catalysts.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Schrödinger is the leading physics-based computational drug discovery platform with LiveDesign, FEP+ and a broad suite covering molecular modeling, docking, QSAR and ADME — directly overlapping VLifeMDS and QSARpro. It is a much larger publicly traded incumbent serving the same pharma, biotech and academic customer base.

TypeDirect peer
Description

Optibrium's StarDrop platform combines QSAR, ADME prediction and lead optimization workflows with a strong European pharma and biotech user base — directly comparable to QSARpro and VLifeSCOPE.

TypeDirect peer
Description

MOE (Molecular Operating Environment) is a long-standing integrated CADD platform for molecular modeling, QSAR and docking with deep adoption among academic and pharma medicinal chemists — overlapping directly with VLifeMDS.

TypeBroad incumbent
Description

ACD/Labs offers cheminformatics and predictive ADME/Tox software (Percepta, Absolv, ACD/ChemSketch) used across pharma and chemistry R&D — adjacent to ChemXplor, ChemDBS and BioPredicta.

TypeDirect peer
Description

OpenEye provides molecular modeling, cheminformatics and ligand-based design software (e.g., OMEGA, FRED, ROCS) that directly competes with VLifeMDS, QSARpro and ChemXplor in pharma and academic discovery workflows.

TypeBroad incumbent
Description

Certara provides modeling and simulation software (e.g., ADMET Predictor, D360, Phoenix) used across pharma discovery, preclinical and clinical stages — adjacent to VLife's ADME/Tox and cheminformatics tools, with broader portfolio scale.

TypeEmerging player
Description

InSilico Medicine is an AI-native drug discovery company offering end-to-end target identification, generative chemistry and PandaOmics/Chemistry42 platforms — an emerging competitor in the same CADD/AI-for-drug-discovery category where VLife's QSAR and GQSAR compete.

TypeDirect peer
Description

Cresset provides ligand-based design (Flare, Spark) with field-based and electrostatic methods that overlap VLife's GQSAR and VLifeSCOPE capabilities, serving pharma and agrochemical discovery teams.

TypeBroad incumbent
Description

Simulations Plus provides ADMET Predictor, GastroPlus and MonolixSuite for modeling pharmacokinetics, PBPK and quantitative systems pharmacology — comparable to VLife's ADME/Tox prediction modules and broader discovery-to-development footprint.

TypeBroad incumbent
Description

BIOVIA offers Discovery Studio and a broad life-science software portfolio covering molecular modeling, QSAR, docking, ADME and biologics, competing head-to-head with VLife's suite across enterprise pharma and CRO customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VLife Sciences Technologies Pvt. Ltd.

Computational Drug Discovery Softwarevlifesciences.com

VLife Sciences Technologies, a Pune-based division of NovaLead Pharma, licenses computational drug discovery software (VLifeMDS, QSARpro, BioPredicta, ChemXplor) and provides research services to pharmaceutical companies, academic institutions, and chemicals/materials firms.

What VLife Sciences Technologies Pvt. Ltd. does

VLife Sciences Technologies Pvt. Ltd. is a Pune, India-based provider of computational molecular discovery and drug design software, operating as a division of NovaLead Pharma Pvt. Ltd. since October 2013. Founded in 2003, the company builds and licenses an integrated software portfolio consisting of four core suites — VLifeMDS (flagship molecular design suite), QSARpro (quantitative structure-activity relationship analysis), BioPredicta (bioinformatics predictive analysis), and ChemXplor (cheminformatics exploration) — complemented by nine functional products covering protein modeling, molecular docking, QSAR modeling, lead optimization, and visualization. The underlying technology stack combines proprietary methods including GQSAR (Group-based QSAR), VLifeSCOPE (residue-ligand interaction modeling), kNN-MFA, and VLifeAutoQSAR for predictive modeling, virtual screening, lead optimization, scaffold hopping, and ADME/Tox prediction, supported by 300+ man-years of accumulated research experience and granted IP including a PCT patent on G-QSAR and an NCE patent on a multi-targeted pancreatic cancer compound discovered using VLife's computational platform.

The company's business model combines software licensing (Individual User and Organizational User subscriptions, quoted on request) with professional research services including NCE discovery and optimization, new indication discovery (IndiSwitch), shelf compound re-evaluation (ReViva), and 360° Go/No-Go decision support (Prometheus/ChemDiagnostic). VLife serves pharmaceutical companies, academic and research institutions, biotech firms, and chemicals/materials industry customers — with named enterprise customers including Sun Pharma, Cipla, Mylan Labs, Unichem, Watson Pharma, Reliance Industries, HUL, and government accounts such as CDC Atlanta, alongside academic users including IISc, IIT Madras, NIPER, and National University of Singapore. Distribution is via direct enterprise licensing, academic institution agreements, and authorized reseller networks in Africa (Inqaba Biotechnical, SNBCHEMTECH) and Korea (Insilicogen).

Demand generation relies on industry conferences (ACS, BioExpo, CPhi India, EuroQSAR), academic training workshops at partner institutions, peer-reviewed publications, an annual Best Research Publication Award, and direct engagement with research institutions. The company holds DSIR R&D facility recognition (2008) and the BIRAC Innovator Award (2015). Operating status remains active with a headcount in the 11-50 range, though most recent customer-agreement news dates to 2015-2018, suggesting limited visible momentum or expansion since.

VLife Sciences Technologies Pvt. Ltd. firmographics

Firmographics
Name
VLife Sciences Technologies Pvt. Ltd.
Legal name
VLife Sciences Technologies Pvt. Ltd.
Website
https://vlifesciences.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
VLife Sciences Technologies, a Pune-based division of NovaLead Pharma, licenses computational drug discovery software (VLifeMDS, QSARpro, BioPredicta, ChemXplor) and provides research services to pharmaceutical companies, academic institutions, and chemicals/materials firms.
Ownership category
akta.pro rank

VLife Sciences Technologies Pvt. Ltd. industry classification

Industry
Product category
Computational Drug Discovery Software
NAICS
Scientific Research and Development Services (5417), Software Publishers (51321)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAE
Cheminformatics & Molecular Modeling / CADD
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAFAM
In Silico / Computational Toxicology & PK/PD Modeling
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

  • Computational drug discovery
  • Molecular modeling software
  • QSAR analysis tools
  • Virtual screening software
  • Computer-aided drug design

Where VLife Sciences Technologies Pvt. Ltd. is headquartered

Location

Headquarters

HQ city
Pune
HQ country
India
HQ region
Asia

Offices1 record

Markets served

VLife Sciences Technologies Pvt. Ltd. business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Software Licensing: VLifeMDS, QSARpro, BioPredicta, ChemXplor - comprehensive software suites for computer-aided drug design and QSAR analysis. Licensed to academic institutions, pharmaceutical companies, and research organizations on subscription or perpetual license basis.
  2. Research Services: NCE discovery & optimization, New Indication discovery, Exploring shelf (Reviva), Go-no go decision support (ChemDiagnostic) - strategic research solutions for pharmaceutical pipeline enhancement.
  3. Technology Services: Custom technology development, research automation, algorithm development, and database management services for specific client needs.
  4. Training Services: Training programs, workshops, and hands-on sessions on computational drug design methods for academic and industry clients.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualIndividual User License
SubscriptionAnnualOrganizational User License

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

VLife Sciences Technologies Pvt. Ltd. product offering

Product offering

Core offering

VLife Sciences Technologies develops and licenses computational molecular discovery and drug design software suites (VLifeMDS, QSARpro, BioPredicta, ChemXplor) that combine molecular modeling, QSAR analysis, virtual screening, protein modeling, and ADME/Tox prediction capabilities. In addition to software licensing, the company delivers strategic research services including NCE discovery and optimization, new indication discovery (IndiSwitch), shelved compound re-evaluation (ReViva), and Go/No-Go decision support (Prometheus), along with custom technology development and training programs for pharmaceutical, biotech, academic, and chemical/materials organizations.

Product overview

VLife Sciences Technologies is a provider of licensed computational drug discovery software and research solutions. The product portfolio consists of four integrated product suites (VLifeMDS, QSARpro, BioPredicta, and ChemXplor) complemented by nine functional products (VLifeBase, VLife Engine, ProModel, VLifeDock, VLifeQSAR, MolSign, LeadGrow, ChemDBS, and ProViz). VLifeMDS serves as the flagship comprehensive molecular modeling suite, while QSARpro focuses on advanced QSAR analysis. The functional products provide specialized capabilities including protein modeling, molecular docking, database management, lead optimization, and visualization, which integrate within the main suites to deliver complete computer-aided drug design workflows.

Differentiator

Problem solved

Functional benefit

Products and services

  • VLifeMDS Comprehensive molecular design and drug discovery software suite providing tools for computer-aided molecular design, QSAR, molecular modeling, virtual screening, and ADME/Tox predictions; licensed to pharmaceutical companies, biotech firms, and academic institutions worldwide.
  • QSARpro Advanced quantitative structure-activity relationship analysis suite for new molecule design and lead optimization; targeted at medicinal chemists performing SAR studies.
  • BioPredicta Bioinformatics product for predictive analysis in drug discovery applications, focused on biological property prediction.
  • ChemXplor Cheminformatics product for chemical data analysis, exploration, and visualization supporting drug discovery workflows.
  • Computational Research Services

Quantifiable outcome

  • First multi-targeted NCE in India for Pancreatic cancer discovered exclusively with computational technologies - now in advanced animal trials
  • +4 more outcomes

Companies that use VLife Sciences Technologies Pvt. Ltd.

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

VLife Sciences Technologies Pvt. Ltd. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

VLife Sciences Technologies Pvt. Ltd. partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core, major, flagship and minor.

  • Sun PharmacoreStrategic or Co-development Partner · 1 October 2015Sun Pharma entered into agreement with VLife for computational drug discovery services. Relationship has been renewed multiple times (2017).
  • Mylan Labs Ltd.coreStrategic or Co-development Partner · 1 January 2015Mylan Labs Hyderabad entered into agreement with VLife for research services.
  • NovaLead Pharma Pvt. Ltd.coreStrategic or Co-development Partner · 1 October 2013VLife Sciences became a division of NovaLead Pharma Private Limited in October 2013, with VLife providing technology platform and NovaLead conducting drug discovery research.
  • Unichem Laboratories Ltd.majorStrategic or Co-development Partner · 1 August 2013Unichem Laboratories entered into service agreement with VLife for drug discovery collaboration.
  • Cipla Ltd.coreStrategic or Co-development Partner · 1 July 2013Cipla entered into service agreement with VLife for drug discovery collaboration. Multiple agreement renewals documented (2014, 2015, 2018).
  • Watson PharmacoreStrategic or Co-development Partner · 1 February 2013Watson Pharma entered into agreement with VLife. Agreement renewed in 2014.
  • Computational Research Laboratories (CRL), Tata GroupflagshipTechnology or Integration · 1 April 2010Strategic partnership to deliver high-speed virtual screening solutions combining VLife's computational drug design technology with CRL's high-performance computing capabilities.
  • National Centre for Biological Sciences (NCBS), BengalurucoreStrategic or Co-development Partner · 1 March 2010VLife contracted to develop specialized modeling and simulation technology for protein-protein interactions. Project undertaken jointly by NCBS, Stanford University (USA), and Technical University of Denmark for cutting-edge computational molecular discovery research.
  • Inqaba Biotechnical (Pty) Ltd.majorChannel Partner/ Reseller/ Distributor · 1 August 2009Appointed as authorized reseller for Africa, expanding VLife's geographic reach in the African market.
  • Insilicogen, Inc.majorChannel Partner/ Reseller/ Distributor · 1 March 2009Appointed as authorized reseller for Republic of Korea, enabling market presence in Korea.
  • SNBCHEMTECHminorChannel Partner/ Reseller/ Distributor · 1 September 2008Appointed as authorized reseller for Africa, expanding distribution network in African regions.
  • Reliance Industries LimitedflagshipStrategic or Co-development Partner · 1 May 2008Research contract renewed for characterization and development of novel catalysts for olefin polymerization, focusing on ethylene oligomerization using Chromium catalysts.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

VLife Sciences Technologies Pvt. Ltd. competitors and assessment

Company assessment

Broad incumbents

  • Schrödinger, Inc. Schrödinger is the leading physics-based computational drug discovery platform with LiveDesign, FEP+ and a broad suite covering molecular modeling, docking, QSAR and ADME — directly overlapping VLifeMDS and QSARpro. It is a much larger publicly traded incumbent serving the same pharma, biotech and academic customer base.
  • ACD/Labs (Advanced Chemistry Development): ACD/Labs offers cheminformatics and predictive ADME/Tox software (Percepta, Absolv, ACD/ChemSketch) used across pharma and chemistry R&D — adjacent to ChemXplor, ChemDBS and BioPredicta.
  • Certara: Certara provides modeling and simulation software (e.g., ADMET Predictor, D360, Phoenix) used across pharma discovery, preclinical and clinical stages — adjacent to VLife's ADME/Tox and cheminformatics tools, with broader portfolio scale.
  • Simulations Plus: Simulations Plus provides ADMET Predictor, GastroPlus and MonolixSuite for modeling pharmacokinetics, PBPK and quantitative systems pharmacology — comparable to VLife's ADME/Tox prediction modules and broader discovery-to-development footprint.
  • Dassault Systèmes BIOVIA: BIOVIA offers Discovery Studio and a broad life-science software portfolio covering molecular modeling, QSAR, docking, ADME and biologics, competing head-to-head with VLife's suite across enterprise pharma and CRO customers.

Direct peers

  • Optibrium: Optibrium's StarDrop platform combines QSAR, ADME prediction and lead optimization workflows with a strong European pharma and biotech user base — directly comparable to QSARpro and VLifeSCOPE.
  • Chemical Computing Group (MOE): MOE (Molecular Operating Environment) is a long-standing integrated CADD platform for molecular modeling, QSAR and docking with deep adoption among academic and pharma medicinal chemists — overlapping directly with VLifeMDS.
  • OpenEye Scientific (Cadence Design Systems): OpenEye provides molecular modeling, cheminformatics and ligand-based design software (e.g., OMEGA, FRED, ROCS) that directly competes with VLifeMDS, QSARpro and ChemXplor in pharma and academic discovery workflows.
  • Cresset: Cresset provides ligand-based design (Flare, Spark) with field-based and electrostatic methods that overlap VLife's GQSAR and VLifeSCOPE capabilities, serving pharma and agrochemical discovery teams.

Emerging players

  • InSilico Medicine: InSilico Medicine is an AI-native drug discovery company offering end-to-end target identification, generative chemistry and PandaOmics/Chemistry42 platforms — an emerging competitor in the same CADD/AI-for-drug-discovery category where VLife's QSAR and GQSAR compete.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

VLife Sciences Technologies Pvt. Ltd. social profiles

Digital presence

VLife Sciences Technologies Pvt. Ltd. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VLife Sciences Technologies Pvt. Ltd. leadership team

Management profile

Number of profiles

Profiles2 records

VLife Sciences Technologies Pvt. Ltd. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VLife Sciences Technologies Pvt. Ltd. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VLife Sciences Technologies Pvt. Ltd.

What does VLife Sciences Technologies Pvt. Ltd. do?

VLife Sciences Technologies develops and licenses computational molecular discovery and drug design software suites (VLifeMDS, QSARpro, BioPredicta, ChemXplor) that combine molecular modeling, QSAR analysis, virtual screening, protein modeling, and ADME/Tox prediction capabilities. In addition to software licensing, the company delivers strategic research services including NCE discovery and optimization, new indication discovery (IndiSwitch), shelved compound re-evaluation (ReViva), and Go/No-Go decision support (Prometheus), along with custom technology development and training programs for pharmaceutical, biotech, academic, and chemical/materials organizations.

Is VLife Sciences Technologies Pvt. Ltd. a public or private company?

VLife Sciences Technologies Pvt. Ltd. is a private company. It is classified as corporate owned and is currently operating.

When was VLife Sciences Technologies Pvt. Ltd. founded?

VLife Sciences Technologies Pvt. Ltd. was founded in 2003. It employs 11 to 50 people.

Where is VLife Sciences Technologies Pvt. Ltd. based?

VLife Sciences Technologies Pvt. Ltd. is headquartered in Pune, India, in the Asia region.

How does VLife Sciences Technologies Pvt. Ltd. make money?

Four revenue lines are on record. Software Licensing is the primary driver. The others are research Services, technology Services and training Services.

Who are VLife Sciences Technologies Pvt. Ltd.'s main competitors?

Broad incumbents on record are Schrödinger, Inc., ACD/Labs (Advanced Chemistry Development), Certara, Simulations Plus and Dassault Systèmes BIOVIA. Direct peers are Optibrium, Chemical Computing Group (MOE), OpenEye Scientific (Cadence Design Systems) and Cresset. InSilico Medicine is listed as an emerging player.

Does VLife Sciences Technologies Pvt. Ltd. have an API?

No public API is recorded for VLife Sciences Technologies Pvt. Ltd..

What industry is VLife Sciences Technologies Pvt. Ltd. in?

VLife Sciences Technologies Pvt. Ltd.'s product category is Computational Drug Discovery Software. Its primary akta.pro industry code is HLAGAJAE, Cheminformatics & Molecular Modeling / CADD, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales